Gilead

3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha
Wed, 04/17/13 - 11:07 am
Flu
H7N9
Sanofi
Novavax
Biocryst
Gilead
GSK
Merck
Roche
Inovio
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
Tue, 04/16/13 - 11:55 am
sofosbuvir
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Merck
Idenix
5 Stocks Pushing The Drugs Industry Downward
TheStreet.com
Mon, 04/15/13 - 03:11 pm
Celgene
Forest Labs
Alexion
Gilead
Bristol-Myers Squibb
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
biotech
M&A
Otsuka
Lundbeck
Gilead
Macrogenics
Roche
Chiasma
Edison Pharma
Dainippon
Moderna
AstraZeneca
Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Yahoo/Fly on the Wall
Tue, 04/9/13 - 10:45 am
sofosbuvir
Gilead
hepatitis C
Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
Seeking Alpha
Thu, 04/4/13 - 09:24 am
Amgen
Amarantus BioSciences
Novartis
Gilead
biotech
Roche
Teva
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Gilead's HCV Study to Continue
Yahoo/Zacks
Tue, 04/2/13 - 10:10 am
hepatitis C
Gilead
sofosbuvir
ledipasvir
Idenix Loses First Phase Of Patent Dispute With Gilead Sciences
TheStreet.com
Mon, 03/25/13 - 12:05 pm
Gilead
Idenix
patents
hepatitis C
sofosbuvir
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Fri, 03/22/13 - 11:45 am
Biogen Idec
Baxter International
Sanofi
Gilead
Europe
BG-12
Tecfidera
Aubagio
HyQvia
Halozyme
Stribild
Vertex: The Sun Sets On Incivek, Rises On Its CF Franchise
Seeking Alpha
Fri, 03/15/13 - 10:57 am
Incivek
Vertex Pharmaceuticals
Gilead
GSK
JNJ
Kalydeco
cystic fibrosis
hepatitis C
Gilead drug reduces chest pain episodes in diabetics -study
Reuters
Mon, 03/11/13 - 11:06 am
diabetes
Gilead
angina
Ranexa
Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha
Fri, 03/8/13 - 11:12 am
biosimilars
Amgen
Affymax
AbbVie
Biogen Idec
Celgene
Fresenius
Merck
Gilead
The Companies Affected By The Cured HIV Patient
Seeking Alpha
Tue, 03/5/13 - 10:51 am
HIV
Abbott Labs
Gilead
GSK
Merck
Pfizer
Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
Bloomberg
Mon, 03/4/13 - 10:59 am
hepatitis C
Gilead
Medivir
sofosbuvir
simeprevir
Hepatitis C In Play for 2013?
Motley Fool
Wed, 02/27/13 - 11:24 am
hepatitis C
BMS-986094
Bristol-Myers Squibb
Gilead
Idenix
Incivek
Achillion
Vertex Pharmaceuticals
Aches And Pains Shouldn't Obscure Achillion's Potential
Seeking Alpha
Fri, 02/22/13 - 10:38 am
Achillion
AbbVie
JNJ
Gilead
Bristol-Myers Squibb
Regulators Await Gilead's Hep C Candidate
Seeking Alpha
Thu, 02/21/13 - 06:39 pm
Gilead
hepatitis C
sofosbuvir
Gilead Settles Teva HIV Drug Patent Suit to Avoid Trial
Bloomberg
Wed, 02/20/13 - 12:05 pm
Teva
patents
HIV
Gilead
Viread
hepatitis B
Gilead hepatitis C drug meets goal of 4th late-stage study
Reuters
Tue, 02/19/13 - 03:24 pm
hepatitis C
Gilead
sofosbuvir

Pages